JP2019518034A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518034A5
JP2019518034A5 JP2018564968A JP2018564968A JP2019518034A5 JP 2019518034 A5 JP2019518034 A5 JP 2019518034A5 JP 2018564968 A JP2018564968 A JP 2018564968A JP 2018564968 A JP2018564968 A JP 2018564968A JP 2019518034 A5 JP2019518034 A5 JP 2019518034A5
Authority
JP
Japan
Prior art keywords
optic
alkyl
medicament according
day
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018564968A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019518034A (ja
JP6872805B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/087341 external-priority patent/WO2017211274A1/en
Publication of JP2019518034A publication Critical patent/JP2019518034A/ja
Publication of JP2019518034A5 publication Critical patent/JP2019518034A5/ja
Priority to JP2021067485A priority Critical patent/JP2021113204A/ja
Application granted granted Critical
Publication of JP6872805B2 publication Critical patent/JP6872805B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018564968A 2016-06-08 2017-06-06 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用 Active JP6872805B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021067485A JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662347103P 2016-06-08 2016-06-08
US62/347,103 2016-06-08
PCT/CN2017/087341 WO2017211274A1 (en) 2016-06-08 2017-06-06 Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021067485A Division JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2019518034A JP2019518034A (ja) 2019-06-27
JP2019518034A5 true JP2019518034A5 (https=) 2020-01-16
JP6872805B2 JP6872805B2 (ja) 2021-05-19

Family

ID=60577583

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018564968A Active JP6872805B2 (ja) 2016-06-08 2017-06-06 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用
JP2021067485A Pending JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021067485A Pending JP2021113204A (ja) 2016-06-08 2021-04-13 奇数個の炭素原子を有する脂質及び医薬組成物又は栄養補助食品としてのそれらの使用

Country Status (12)

Country Link
US (2) US11406616B2 (https=)
EP (1) EP3468551A4 (https=)
JP (2) JP6872805B2 (https=)
KR (1) KR20190017873A (https=)
CN (2) CN110300581B (https=)
AU (1) AU2017277005B2 (https=)
CL (1) CL2018003537A1 (https=)
MX (1) MX2018015188A (https=)
NZ (1) NZ749389A (https=)
SG (1) SG11201810580PA (https=)
TW (1) TWI749016B (https=)
WO (1) WO2017211274A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019052629A1 (en) * 2017-09-12 2019-03-21 Sunregen Healthcare Ag LIPIDS HAVING AN IMPERATIVE NUMBER OF CARBON ATOMS AND THEIR USE AS A PHARMACEUTICAL COMPOSITION OR FOOD SUPPLEMENT
CN111773274A (zh) * 2019-09-20 2020-10-16 厦门医学院 瓶尔小草及车前子组合物在制备降血糖及降血压的药物组合物中的应用
CN111773351A (zh) * 2019-09-20 2020-10-16 厦门医学院 瓶尔小草及姜黄组合物在制备降血糖及降血压的药物组合物中的应用
JP7685134B2 (ja) * 2019-11-27 2025-05-29 リファインホールディングス株式会社 インスリン分泌促進剤並びにこれを用いた血糖値改善剤、糖尿病改善剤及び食品
WO2022263624A1 (en) * 2021-06-18 2022-12-22 Sunregen Healthcare Ag Novel compounds for the treatment and prevention of neurological complications of viral infections
JP2023061448A (ja) * 2021-10-20 2023-05-02 リファインホールディングス株式会社 小胞体ストレス抑制剤、神経変性疾患予防改善剤および認知症の予防・進行防止・改善剤、並びに食品
JPWO2024075625A1 (https=) * 2022-10-02 2024-04-11

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS558351A (en) 1978-07-05 1980-01-21 Hitachi Ltd Press machine
DE3032300A1 (de) 1980-08-27 1982-04-01 Alfred Ing. Wien Lohninger Mittel zur parenteralen ernaehrung
JPS5919775U (ja) 1982-07-26 1984-02-06 ワイケイケイ株式会社 カ−テンウオ−ルの断熱窓
CA1244772A (en) 1983-06-21 1988-11-15 Kuniaki Adachi Cell-stimulating composition
JPH02247125A (ja) 1989-03-17 1990-10-02 Koken Kk 悪性腫瘍細胞増殖抑制剤
JP3558351B2 (ja) 1992-12-07 2004-08-25 邦郎 辻 免疫抑制剤
DE19821003A1 (de) * 1998-05-11 1999-11-18 Dresden Arzneimittel Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2001257451A1 (en) 2000-05-01 2001-11-12 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
AU2001264079A1 (en) 2000-06-14 2001-12-24 William Leslie Porter Lipids for modulating immune response
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
IL158322A0 (en) 2001-04-18 2004-05-12 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
CN1764446A (zh) * 2003-03-13 2006-04-26 康福玛医药公司 含有长链和中链甘油三酯的药物制剂
US8399515B2 (en) 2003-05-20 2013-03-19 Baylor Research Institute Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
JP4334956B2 (ja) 2003-09-18 2009-09-30 株式会社ノエビア 細胞賦活剤、美白剤、及び抗酸化剤
CN101137369A (zh) * 2005-02-09 2008-03-05 马库赛特公司 用于眼治疗的制剂
WO2008039855A2 (en) 2006-09-26 2008-04-03 Baylor Research Institute Nutrient sensor
EP1929995A1 (en) 2006-12-04 2008-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Anaplerotic therapy of Huntington disease and other polyglutamine diseases
KR100829729B1 (ko) * 2007-01-29 2008-05-15 한불화장품주식회사 병이소초 추출물을 주요 활성성분으로 함유하는 피부외용제 조성물
CN101878028A (zh) 2007-11-02 2010-11-03 普罗米蒂克生物科学公司 作为肾保护剂的中链长度脂肪酸和甘油酯
DE102008046227A1 (de) * 2008-06-10 2009-12-17 Ludwig-Maximilians-Universität München Hochdurchsatzmethode zur Analyse der Fettsäurezusammensetzung in Plasmaphosphoglyceriden
DE102008057867A1 (de) 2008-11-18 2010-05-20 B. Braun Melsungen Ag Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten
CN101879156B (zh) 2009-05-07 2013-01-30 上海医药工业研究院 一种药物组合物及其应用
CA2785714C (en) 2009-12-30 2016-01-26 Baylor Research Institute Anaplerotic therapy for alzheimer's disease and the aging brain
JP5771627B2 (ja) * 2010-01-08 2015-09-02 カタバシス ファーマシューティカルズ，インコーポレイテッド 脂肪酸フマル酸塩誘導体およびそれらの使用
WO2011099570A1 (ja) * 2010-02-10 2011-08-18 オリザ油化株式会社 Ａｇｅ産生抑制剤
US20110301238A1 (en) 2010-06-02 2011-12-08 Borges Karin Seizure related disorders and therapeutic methods thereof
CN103079555A (zh) 2010-06-14 2013-05-01 贝勒研究院 用于成人葡萄糖多聚体病（apbd）治疗的三庚酸甘油酯膳食
EP2407155B1 (en) * 2010-07-15 2012-12-26 Hybrigenics S.A. Formulations of inecalcitol
WO2013031729A1 (ja) 2011-08-26 2013-03-07 国立大学法人大阪大学 糖尿病性心血管合併症の予防・治療剤
CN102526643B (zh) * 2012-03-22 2013-09-11 常熟市虞山绿茶有限公司 一种治疗口腔溃疡的中草药含片
ES2728727T3 (es) 2012-12-13 2019-10-28 Baylor Res Institute At Dallas Triheptanoína para el tratamiento de la deficiencia del transportador de glucosa 1
US10751282B2 (en) * 2013-08-02 2020-08-25 Schweitzer-Mauduit International, Inc. Edible product comprising reconstituted plant material
US9833430B2 (en) * 2013-11-14 2017-12-05 The University Of Queensland Neurodegenerative disorders and methods of treatment and diagnosis thereof
CN103641713B (zh) * 2013-11-15 2015-10-21 浙江大学 甘油单酯衍生物的制备方法及应用
WO2015110977A1 (en) 2014-01-22 2015-07-30 Rolexi Marketing (Pty) Ltd Fatty acid composition and medicinal use thereof
CN104286296A (zh) * 2014-09-25 2015-01-21 王美华 一种凉茶
JP6406978B2 (ja) 2014-11-04 2018-10-17 株式会社シー・アクト 脂肪酸混合物
CN105267501A (zh) * 2015-11-04 2016-01-27 夏茂森 一种治疗毒蛇咬伤的中药组合物
CN105381182A (zh) 2015-11-20 2016-03-09 冯天寿 一种治疗慢性荨麻疹的中药及其应用
CA3004996A1 (en) 2015-12-04 2017-06-08 Nestec S.A. Method for improving cognition

Similar Documents

Publication Publication Date Title
JP2019518034A5 (https=)
JP2015532295A5 (https=)
EP4616908A3 (en) Oxysterols and methods of use thereof
JP2015518001A5 (https=)
JP2016538257A5 (https=)
EP4410317A3 (en) Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP2014528485A5 (https=)
JP2022506111A5 (https=)
JP2017526677A5 (https=)
JP2019535723A5 (https=)
EP4275748A3 (en) Compositions and methods for treating cns disorders
NZ749389A (en) Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
JP2013500314A5 (https=)
JP2016513130A5 (https=)
JP2016506916A5 (https=)
WO2009082819A8 (en) Novel lupane derivatives
JP2019507764A5 (https=)
JP2021503449A5 (https=)
JP2018538273A5 (https=)
JP2016531871A5 (https=)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
MX2021012491A (es) Agentes antiproliferativos para el tratamiento de la hipertensión arterial pulmonar.
JP2019519593A5 (https=)
JP2018521056A5 (https=)
JP2009539943A5 (https=)